Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123320083 | 12332008 | 3 | F | 20160621 | 20160504 | 20160713 | PER | US-PFIZER INC-2016208066 | PFIZER | 68.00 | YR | F | Y | 0.00000 | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123320083 | 12332008 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 400 MG, 1X/DAY, AT BED | 20235 | 400 | MG | CAPSULE, HARD | QD | ||||||
| 123320083 | 12332008 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 400 MG, 2X/DAY, IN THE MORNING AND AT NIGHT | 20235 | 400 | MG | CAPSULE, HARD | BID | ||||||
| 123320083 | 12332008 | 3 | C | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | 0 | 100 | MG | TID | ||||||||
| 123320083 | 12332008 | 4 | C | LYRICA | PREGABALIN | 1 | 450 MG, DAILY, 100 MG 3X/DAY AND 150 MG AT BEDTIME | 0 | 450 | MG | |||||||||
| 123320083 | 12332008 | 5 | C | LYRICA | PREGABALIN | 1 | 450 MG, 1X/DAY, AT BEDTIME | 0 | 450 | MG | QD | ||||||||
| 123320083 | 12332008 | 6 | C | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY, MORNING ,NOON, AND NIGHT | 0 | 100 | MG | TID | ||||||||
| 123320083 | 12332008 | 7 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 123320083 | 12332008 | 8 | C | BRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | QD | ||||||||
| 123320083 | 12332008 | 9 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 123320083 | 12332008 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 150 MG, 1X/DAY | 0 | 150 | MG | TABLET | QD | |||||||
| 123320083 | 12332008 | 11 | C | SOTALOL. | SOTALOL | 1 | 18 MG, 2X/DAY, MORNING AND AT NIGHT | 0 | 18 | MG | BID | ||||||||
| 123320083 | 12332008 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | 40 MG, 1X/DAY, AT BED TIME | 0 | 40 | MG | QD | ||||||||
| 123320083 | 12332008 | 13 | C | ESOMEPRAZOLE MAGNESIUM. | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, 1X/DAY, IN THE MORNING | 0 | 40 | MG | QD | ||||||||
| 123320083 | 12332008 | 14 | C | PEPCID | FAMOTIDINE | 1 | 20 MG, 1X/DAY, AT BEDTIME | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123320083 | 12332008 | 1 | Sleep disorder |
| 123320083 | 12332008 | 3 | Pain |
| 123320083 | 12332008 | 4 | Fibromyalgia |
| 123320083 | 12332008 | 8 | Depression |
| 123320083 | 12332008 | 9 | Depression |
| 123320083 | 12332008 | 10 | Hypothyroidism |
| 123320083 | 12332008 | 11 | Supraventricular tachycardia |
| 123320083 | 12332008 | 12 | Blood cholesterol increased |
| 123320083 | 12332008 | 13 | Gastrooesophageal reflux disease |
| 123320083 | 12332008 | 14 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123320083 | 12332008 | Drug ineffective for unapproved indication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123320083 | 12332008 | 1 | 201601 | 0 | ||
| 123320083 | 12332008 | 2 | 201604 | 0 | ||
| 123320083 | 12332008 | 4 | 201601 | 0 |